vs

Side-by-side financial comparison of Elme Communities (ELME) and PROCEPT BioRobotics Corp (PRCT). Click either name above to swap in a different company.

PROCEPT BioRobotics Corp is the larger business by last-quarter revenue ($83.1M vs $62.1M, roughly 1.3× Elme Communities). PROCEPT BioRobotics Corp runs the higher net margin — -38.1% vs -198.9%, a 160.8% gap on every dollar of revenue. On growth, PROCEPT BioRobotics Corp posted the faster year-over-year revenue change (20.2% vs 1.7%). Over the past eight quarters, PROCEPT BioRobotics Corp's revenue compounded faster (24.8% CAGR vs 2.7%).

Elme Communities is a publicly traded U.S. real estate investment trust that primarily owns, operates and develops high-quality multifamily residential communities. It focuses on key growth markets across the U.S. Mid-Atlantic and Southeast, offering affordable to mid-tier housing options for diverse renter groups.

PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.

ELME vs PRCT — Head-to-Head

Bigger by revenue
PRCT
PRCT
1.3× larger
PRCT
$83.1M
$62.1M
ELME
Growing faster (revenue YoY)
PRCT
PRCT
+18.5% gap
PRCT
20.2%
1.7%
ELME
Higher net margin
PRCT
PRCT
160.8% more per $
PRCT
-38.1%
-198.9%
ELME
Faster 2-yr revenue CAGR
PRCT
PRCT
Annualised
PRCT
24.8%
2.7%
ELME

Income Statement — Q3 FY2025 vs Q1 FY2026

Metric
ELME
ELME
PRCT
PRCT
Revenue
$62.1M
$83.1M
Net Profit
$-123.5M
$-31.6M
Gross Margin
61.1%
64.9%
Operating Margin
-183.3%
-4.1%
Net Margin
-198.9%
-38.1%
Revenue YoY
1.7%
20.2%
Net Profit YoY
-4058.7%
-27.9%
EPS (diluted)
$-1.40
$-0.56

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ELME
ELME
PRCT
PRCT
Q1 26
$83.1M
Q4 25
$76.4M
Q3 25
$62.1M
$83.3M
Q2 25
$62.1M
$79.2M
Q1 25
$61.5M
$69.2M
Q4 24
$61.3M
$68.2M
Q3 24
$61.1M
$58.4M
Q2 24
$60.1M
$53.4M
Net Profit
ELME
ELME
PRCT
PRCT
Q1 26
$-31.6M
Q4 25
$-29.8M
Q3 25
$-123.5M
$-21.4M
Q2 25
$-3.6M
$-19.6M
Q1 25
$-4.7M
$-24.7M
Q4 24
$-3.0M
$-18.9M
Q3 24
$-3.0M
$-21.0M
Q2 24
$-3.5M
$-25.6M
Gross Margin
ELME
ELME
PRCT
PRCT
Q1 26
64.9%
Q4 25
60.6%
Q3 25
61.1%
64.8%
Q2 25
63.5%
65.4%
Q1 25
64.2%
63.9%
Q4 24
62.9%
64.0%
Q3 24
63.5%
63.2%
Q2 24
63.4%
59.0%
Operating Margin
ELME
ELME
PRCT
PRCT
Q1 26
-4.1%
Q4 25
-40.6%
Q3 25
-183.3%
-27.8%
Q2 25
9.6%
-28.0%
Q1 25
7.8%
-39.7%
Q4 24
10.4%
-28.9%
Q3 24
11.0%
-38.4%
Q2 24
9.8%
-50.3%
Net Margin
ELME
ELME
PRCT
PRCT
Q1 26
-38.1%
Q4 25
-39.1%
Q3 25
-198.9%
-25.7%
Q2 25
-5.7%
-24.7%
Q1 25
-7.6%
-35.8%
Q4 24
-4.9%
-27.6%
Q3 24
-4.9%
-35.9%
Q2 24
-5.8%
-48.0%
EPS (diluted)
ELME
ELME
PRCT
PRCT
Q1 26
$-0.56
Q4 25
$-0.54
Q3 25
$-1.40
$-0.38
Q2 25
$-0.04
$-0.35
Q1 25
$-0.05
$-0.45
Q4 24
$-0.04
$-0.34
Q3 24
$-0.03
$-0.40
Q2 24
$-0.04
$-0.50

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ELME
ELME
PRCT
PRCT
Cash + ST InvestmentsLiquidity on hand
$7.1M
$245.6M
Total DebtLower is stronger
$51.7M
Stockholders' EquityBook value
$908.9M
$347.7M
Total Assets
$1.7B
$487.1M
Debt / EquityLower = less leverage
0.15×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ELME
ELME
PRCT
PRCT
Q1 26
$245.6M
Q4 25
$286.5M
Q3 25
$7.1M
$294.3M
Q2 25
$4.8M
$302.7M
Q1 25
$6.4M
$316.2M
Q4 24
$6.1M
$333.7M
Q3 24
$4.8M
$196.8M
Q2 24
$5.6M
$214.1M
Total Debt
ELME
ELME
PRCT
PRCT
Q1 26
$51.7M
Q4 25
$51.6M
Q3 25
$51.6M
Q2 25
$51.5M
Q1 25
$51.5M
Q4 24
$51.5M
Q3 24
$51.4M
Q2 24
$51.4M
Stockholders' Equity
ELME
ELME
PRCT
PRCT
Q1 26
$347.7M
Q4 25
$365.9M
Q3 25
$908.9M
$380.3M
Q2 25
$1.0B
$385.8M
Q1 25
$1.1B
$389.2M
Q4 24
$1.1B
$402.2M
Q3 24
$1.1B
$241.2M
Q2 24
$1.1B
$251.8M
Total Assets
ELME
ELME
PRCT
PRCT
Q1 26
$487.1M
Q4 25
$508.1M
Q3 25
$1.7B
$511.5M
Q2 25
$1.8B
$513.1M
Q1 25
$1.8B
$519.4M
Q4 24
$1.8B
$534.0M
Q3 24
$1.9B
$374.1M
Q2 24
$1.9B
$374.4M
Debt / Equity
ELME
ELME
PRCT
PRCT
Q1 26
0.15×
Q4 25
0.14×
Q3 25
0.14×
Q2 25
0.13×
Q1 25
0.13×
Q4 24
0.13×
Q3 24
0.21×
Q2 24
0.20×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ELME
ELME
PRCT
PRCT
Operating Cash FlowLast quarter
$15.9M
Free Cash FlowOCF − Capex
$7.2M
FCF MarginFCF / Revenue
11.6%
Capex IntensityCapex / Revenue
14.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$86.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ELME
ELME
PRCT
PRCT
Q1 26
Q4 25
$-10.3M
Q3 25
$15.9M
$-6.6M
Q2 25
$29.8M
$-15.0M
Q1 25
$16.2M
$-17.0M
Q4 24
$95.2M
$-32.4M
Q3 24
$20.7M
$-18.8M
Q2 24
$28.9M
$-15.7M
Free Cash Flow
ELME
ELME
PRCT
PRCT
Q1 26
Q4 25
$-12.2M
Q3 25
$7.2M
$-9.5M
Q2 25
$21.1M
$-17.8M
Q1 25
$10.5M
$-18.8M
Q4 24
$47.9M
$-33.6M
Q3 24
$8.8M
$-19.0M
Q2 24
$21.0M
$-16.8M
FCF Margin
ELME
ELME
PRCT
PRCT
Q1 26
Q4 25
-15.9%
Q3 25
11.6%
-11.4%
Q2 25
34.1%
-22.5%
Q1 25
17.1%
-27.2%
Q4 24
78.1%
-49.2%
Q3 24
14.4%
-32.6%
Q2 24
34.9%
-31.4%
Capex Intensity
ELME
ELME
PRCT
PRCT
Q1 26
Q4 25
2.4%
Q3 25
14.0%
3.4%
Q2 25
14.0%
3.5%
Q1 25
9.2%
2.7%
Q4 24
77.4%
1.7%
Q3 24
19.4%
0.4%
Q2 24
13.1%
2.0%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ELME
ELME

Residential Segment$57.7M93%
Other$4.4M7%

PRCT
PRCT

Handpieces and other consumables$43.0M52%
System sales and rentals$23.4M28%
Other$11.1M13%
Service$5.6M7%

Related Comparisons